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Abstract
Background: CCN2/CTGF is known to be involved in tooth germ development and periodontal
tissue remodeling, as well as in mesenchymal tissue development and regeneration. In this present
study, we investigated the roles of CCN2/CTGF in the proliferation and differentiation of
periodontal ligament cells (murine periodontal ligament-derived cell line: MPL) in vitro.
Results: In cell cultures of MPL, the mRNA expression of the CCN2/CTGF gene was stronger in
sparse cultures than in confluent ones and was significantly enhanced by TGF-β. The addition of
recombinant CCN2/CTGF (rCCN2) to MPL cultures stimulated DNA synthesis and cell growth in
a dose-dependent manner. Moreover, rCCN2 addition also enhanced the mRNA expression of
alkaline phosphatase (ALPase), type I collagen, and periostin, the latter of which is considered to
be a specific marker of the periosteum and periodontium; whereas it showed little effect on the
mRNA expression of typical osteoblastic markers, e.g., osteopontin and osteocalcin. Finally,
rCCN2/CTGF also stimulated ALPase activity and collagen synthesis.
Conclusion:  These results taken together suggest important roles of CCN2/CTGF in the
development and regeneration of periodontal tissue including the periodontal ligament.
Background
Connective tissue growth factor (CCN2/CTGF) is a
cysteine-rich protein with a molecular weight of 36–38
kDa [1-3] and belongs to the CCN family, which stands
for CTGF, CEF10/Cyr61, and Nov [4]. This family now
consists of 6 distinct members [1-3], including additional
members that had been named WISP1/ELM1, WISP2/
COP-1, and WISP3. These proteins retain structural simi-
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larity to one another, characterized by an N-terminal
secretory signal, followed by 4 modules, with the excep-
tion of COP-1, which lacks the C-terminal module [1-4].
As such, CCN proteins share 30–50% over all amino acid
sequence homology and 40–60% nucleotide sequence
homology with each other [1-4]. The members of this
family exhibit functional diversity, being involved in such
cellular processes as adhesion, migration, proliferation
and differentiation, and in biological processes such as
angiogenesis and chondrogenesis [1-3].
CCN2/CTGF was discovered as a chemotactic and
mitogenic factor for fibroblast-like cells in vitro and so was
named accordingly [5]. It was also found in skin fibrob-
lasts in vivo as a repairing growth factor [6]. Of note, trans-
forming growth factor (TGF)-β was shown to act in tissue
during normal wound repair [6,7] and fibrotic disorders
of the skin [8,9], and in internal organs and tissues [10-
12]. CCN2/CTGF was also shown to be closely linked to
the expression of TGF-β in these situations [6].
CCN2/CTGF increased the expression of extracellular
matrix molecules such as type I collagen, fibronectin, and
integrin [13], and was overexpressed in fibroblasts in the
dermis of patients with scleroderma [14] or other fibrotic
disorders [15-18]. These findings suggest that CCN2/
CTGF plays an important role in cell proliferation and
matrix synthesis in connective tissue.
Critical roles of CCN2/CTGF in other mesenchymal tis-
sues have been uncovered as well. Our previous studies
revealed that ccn2/ctgf  was highly expressed in hyper-
trophic chondrocytes in growth cartilage and human
chondrocytic HCS-2/8 cells [19]. CCN2/CTGF actually
stimulated the proliferation and differentiation of
chondrocytes in vitro [20] and induced articular cartilage
regeneration in vivo [21]. Importantly, CCN2/CTGF also
promotes the proliferation, migration, and tube forma-
tion of vascular endothelial cells in vitro and angiogenesis
in vivo [22,23]. Such biological effects of CCN2/CTGF
were further confirmed by the abnormal phenotypic
change in the growth plate of CCN2/CTGF knockout
mice. Moreover, roles of CCN2/CTGF in the proliferation
and differentiation of osteoblasts have been also indi-
cated [24]. In a recent study, regulated expression of
CCN2/CTGF in developing tooth germs was reported
[25,26]. During odontogenesis, CTGF/CCN2 gene expres-
sion was clearly observed not only in the dental mesen-
chyme but also in the dental epithelium up to the stage of
enamel secretion [25,26]. Therefore, CCN2/CTGF is now
regarded as a common regulator of the development of
the 2 hard tissues in vertebrates – tooth and bone.
The periodontal ligament is a fibrous tissue located
between these 2 mineralized hard tissues, and plays an
important role in anchoring tooth and alveolar bone and
in maintaining their structural integrity; and it is also
involved in the periodontal regeneration process. The lig-
ament consists of a number of different cell types, such as
fibroblasts, osteoblasts, osteoclasts, cementoblasts, and
their precursors, and so on. In particular, fibroblasts in the
periodontal ligament are considered to be multi-potential
cells, or heterogeneous cell populations, which have the
capacity to differentiate into other types of cells. In this
respect, the periodontal ligament fibroblasts supposedly
play a key role in the formation, maintenance, and regen-
eration of this connective tissue.
Therefore, in the present study, we focused on these peri-
odontal ligament fibroblasts by evaluating the effects of
CCN2/CTGF on the in vitro biological phenotypes of a
mouse periodontal ligament cell line (MPL).
Results
Expression of ccn2/ctgf mRNA in different growth phases 
in MPL cell cultures
Initially, the expression of ccn2/ctgf  mRNA in different
phases of MPL growth was analyzed by in situ hybridiza-
tion analysis. Positive signals were significantly observed
in sparse cultures, but not in confluent ones. However,
stronger mRNA expression was induced by the addition of
TGF-β, even in cultures in the confluent state (Fig. 1).
Since strong expression of ccn2/ctgf mRNA was detected in
sparse cultures of MPL by in situ hybridization analysis, we
subsequently evaluated the expression level in different
growth phases by semi-quantitative RT-PCR. The steady-
state mRNA level in the sparse cultures of MPL cells was
approximately 3 times higher than that in the confluent
ones (Fig. 2). These results suggest the involvement of
CCN2/CTGF and TGF-β in MPL cell proliferation on
demand during the regeneration of periodontal ligament.
Effects of rCCN2/CTGF on DNA synthesis and cell 
proliferation
Based on the findings above, we next evaluated the effects
of exogenous rCCN2/CTGF on MPL cell growth. As
shown in Fig. 3A, rCCN2/CTGF stimulated DNA synthesis
in the cells in a dose-dependent manner, as evaluated by
[3H] thymidine incorporation. Significant effects were
observed at 1 ng/ml and higher concentrations of rCCN2/
CTGF. Similarly, the addition of rCCN2/CTGF increased
the cell number under standard cell culture conditions
after 3 days of treatment (Fig. 3B). The maximum effect
produced a 1.2-fold increase over the control.Cell Communication and Signaling 2005, 3:11 http://www.biosignaling.com/content/3/1/11
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Effects of rCCN2/CTGF on expression of genes related to 
the differentiated phenotypes of periodontal ligament 
(PDL) cells
In order to examine the effects of rCCN2/CTGF on gene
expression of known mesenchymal differentiation mark-
ers, we conducted RT-PCR analysis. The mRNA expression
of ALPase and type I collagen, which are considered to be
phenotypic markers of periodontal ligament (PDL) cells
as well as of osteoblasts, was up-regulated 24 hrs after the
addition of 100 ng/ml of rCCN2/CTGF (ALPase: about
2.8-fold, type I collagen: about 1.5-fold; Fig. 4). Moreover,
the expression of periostin, which is a marker of periosteal
cells as well as of PDL cells, was also up-regulated approx-
imately 2.5-fold 24 hrs after the addition of rCCN2/CTGF.
On the other hand, the addition of rCCN2/CTGF had lit-
tle effect on the mRNA expression of bone-specific pheno-
typic marker genes encoding osteopontin and osteocalcin
(data not shown). The amount of GAPDH transcript, used
as an internal control, was almost the same with or with-
out rCCN2/CTGF.
Expression of CCN2/CTGF mRNA in sparse and confluent MPL cultures (in situ hybridization) with or without TGF-β  stimulation Figure 1
Expression of CCN2/CTGF mRNA in sparse and confluent MPL cultures (in situ hybridization) with or without 
TGF-β stimulation. MPL cultures in the sparsity phase (A and B) and confluence phase (C and D) were treated with TGF-β 
(B and D) or PBS (control: A and C). The cells were then cultured for 12 hrs, fixed, and hybridized with an antisense riboprobe 
for ccn2/ctgf mRNA. CCN2/CTGF mRNA was distinctly expressed in the cells in the sparse (A), but not in those in the conflu-
ent (C) state. However, the addition of TGF-β enhanced the level of CCN2/CTGF mRNA strongly, not only in the sparse cul-
tures (B), but also in the confluent ones (D).Cell Communication and Signaling 2005, 3:11 http://www.biosignaling.com/content/3/1/11
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Effect of rCCN2/CTGF on ALPase Activity displayed by 
MPL cells
In addition to the examination of the mRNA level, we also
investigated the effect of rCCN2/CTGF on ALPase activity
displayed by MPL cells. As shown in Fig. 5, the enzyme
activity increased in a dose-dependent manner 48 hrs after
the addition of rCCN2/CTGF. A significant effect was
observed at a dose as low as 1 ng/ml, reaching a plateau at
100 ng/ml.
Effect of rCCN2/CTGF on collagen synthesis by MPL cells
Since the predominant component of the extracellular
matrix of the periodontal ligament is type I collagen, we
further examined the effect of rCCN2/CTGF on collagen
synthesis by MPL cells. As shown in Fig. 6, both total pro-
tein synthesis and collagen synthesis were increased by
the addition of rCCN2/CTGF in a dose-dependent man-
ner. However, the collagen-specific increase in [3H]-pro-
line incorporation as estimated by collagenase digestion
was significantly higher than that of the total increase.
Therefore, CCN2/CTGF was indicated to promote the
expression of PDL cell phenotypes, as well as overall pro-
tein synthesis, which might be the outcome of stimulated
cell proliferation.
Discussion
Active roles of CCN2/CTGF in tooth development and
remodeling of periodontal tissues have been suggested by
several reports that described the stage-specific expression
of ccn2/ctgf with a particular spatial distribution in corre-
sponding tissues [25,26]. In view of these reports, CCN2/
CTGF is suggested to have some physiological function,
playing a role in the organization and maintenance of per-
iodontal tissues.
TGF-β, a major stimulator of the ccn2/ctgf  gene, is
expressed broadly in rat molar periodontal tissue in late
embryos and after birth [36,37]. CCN2/CTGF expression
was induced by TGF-β, but not by PDGF, EGF, or bFGF in
cultured human foreskin fibroblasts [6]; and in a wound
healing model, TGF-β and CCN2/CTGF mRNAs were
coordinately expressed [6]. Therefore, as CCN2/CTGF has
been shown to be closely linked to the expression of TGF-
β, the CCN2/CTGF gene might be induced by TGF-β in
periodontal tissue. Indeed, interaction between dental
epithelium and mesenchyme was required for CCN2/
CTGF induction, which could be substituted by exoge-
nous TGF-β [25]. In our present study, TGF-β actually
induced ccn2/ctgf expression in MPL cells and might be
involved in the growth phase-dependent ccn2/ctgf expres-
sion. Therefore, interplay of TGF-β and CCN2/CTGF dur-
ing tooth development is indicated as well.
The periodontal ligament lies between 2 hard tissues,
alveolar bone and cementum, and consists of various
kinds of cells. Owing to this specific situation, the major
constituent cells – periodontal ligament fibroblasts – have
unique characteristics unlike other fibroblasts. Periodon-
tal ligament fibroblasts express calcification-related genes,
and show ALPase activity. Although their functional sig-
nificance is unclear, these phenotypes are thought to be
critically important for fulfilling the specific missions of
PDL cells.
As was shown in Fig. 1, positive signals for CCN2/CTGF
mRNA in sparse MPL cultures were distinctly detected by
in situ hybridization analysis, but were not clearly seen in
confluent cells. We next evaluated the proliferative effect
RT-PCR analysis of the expression of CCN2/CTGF mRNA in  sparse (S) and confluent (C) MPL cultures Figure 2
RT-PCR analysis of the expression of CCN2/CTGF 
mRNA in sparse (S) and confluent (C) MPL cultures. 
Total RNA was purified from MPL cultures under sparse and 
confluent conditions, and 1 µg in each sample was reverse 
transcribed and used for PCR. The expression of CCN2/
CTGF mRNA was stronger under the sparse than the conflu-
ent condition as evaluated in the exponential phase of the 
amplification (25 cycles). Levels of GAPDH mRNA, used as 
an internal control, were almost the same among these 
samples.Cell Communication and Signaling 2005, 3:11 http://www.biosignaling.com/content/3/1/11
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of rCCN2/CTGF on MPL cells. Regarding DNA synthesis,
the incorporation of [3H] thymidine was increased in a
dose-dependent manner by rCCN2/CTGF (Fig. 3A), and
cell growth was stimulated in the same manner (Fig. 3B).
These results suggest that CCN2/CTGF acts as an autocrine
and/or paracrine cell proliferation-inducing factor. In
addition, in our experiments, the stimulatory effect of
rCCN2/CTGF on DNA synthesis was lost when MPL cells
were cultured with α-MEM supplemented with 10% FBS,
suggesting that more potent growth factors than rCCN2/
CTGF are present in FBS.
In our RT-PCR investigation, the mRNA expression of
ALPase and of type I collagen was up-regulated 24 hrs
after the stimulation with rCCN2/CTGF (Fig. 4). In addi-
tion, rCCN2/CTGF stimulated the ALPase activity (Fig. 5).
In the course of the calcification of hard tissues, including
that of MPL cells in cell culture, the ALPase level is first up-
regulated, the expression levels of osteopontin and osteo-
calcin are then up-regulated, and finally calcification
occurs [38]. However, the gene expression of osteopontin
and osteocalcin was not up regulated by CCN2/CTGF.
Since we previously evaluated the cell biological effects of
CCN2/CTGF on osteoblastic cells as well, the effects of
CCN2/CTGF on the differentiation markers are compara-
tively summarized in Table 1. Such restricted expression
of calcification-related genes may represent the specific
phenotype of PDL cells, which discriminate them from
osteoblasts. It should be also noted that the expression of
osf-2/cbfa1, a master gene of osteoblastic differentiation,
(A) Effect of rCCN2/CTGF on DNA synthesis in MPL cells Figure 3
(A) Effect of rCCN2/CTGF on DNA synthesis in MPL cells. MPL cells were inoculated at a density of 5 × 103/well in 
96-multi-well plates and cultured in α-MEM with 10% FBS for 2 days. Then, the culture medium was changed to α-MEM with 
0.5% FBS, and the cells were incubated with various concentrations of rCCN2/CTGF for 24 hrs and labeled with [3H] thymi-
dine for the last 4 hrs. The incorporated radioactivity was determined by a liquid scintillation counter. Values represent the 
averages ± SD. Data were computed with the results of 2 independent series of experiments with multiple sample numbers. 
Asterisks denote statistically significant difference from the vehicle-treated control. (B) Effect of rCCN2/CTGF on the 
proliferation of MPL cells. MPL cells were inoculated at a density of 2 × 103/well in 96-multi-well plates and cultured in α-
MEM with 10% FBS for 24 hrs. Then, the medium was changed to α-MEM with 1% FBS, and the cells were cultured with vari-
ous concentrations of rCCN2/CTGF for 3 days. The cell number was computed by using Tetra-Color One as specified by the 
manufacturer. Points and bars represent the averages and SD, respectively. Asterisks indicate significant differences between 
vehicle-treated control and rCCN2/CTGF-treated samples at the significance level of **p < 0.01 or *p < 0.05.Cell Communication and Signaling 2005, 3:11 http://www.biosignaling.com/content/3/1/11
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was not detectable in MPL cells. The observed effects of
CCN2/CTGF to promote the proper differentiated
phenotype of each type of the cells represent the
characteristics of CCN2/CTGF as a modulator of extracel-
lular signalling network.
As for periodontal ligament fibroblasts, there is no clear
differentiation marker that is specifically characteristic of
this type of cell [39]. Thus, osteoblast-related markers
have usually been used, although the ligament is an elastic
tissue. However, in 1995, periostin cDNA was cloned
from the MC3T3-E1 cell line by Takeshita et.al. [40]. They
reported its stimulatory effect on cell-cell attachment and
migration of MC3T3-E1 cells. Later, its limited expression
was detected in both the periosteum and periodontium of
teeth [41]. It was also reported that its strong expression
in the periosteum was due to that in putative pre-osteob-
lasts and that this expression decreased as these pre-oste-
oblasts underwent maturation [40], indicating that
periostin gene expression is a differentiation marker for
immature, osteoblast progenitor cells. Gene expression of
periostin is also detected in periodontium of teeth [41],
which is also an elastic membranous tissue close to calci-
fied-tissues, as is periostium, thus indicating that periostin
gene expression is a marker of not only the periosteum
but also of the periodontium. In other words, periostin is
a marker of cells that are present close to calcified tissues
and have potential to calcify but retain characteristics of
an elastic, membranous tissue. Therefore, our finding that
CCN2/CTGF potently stimulated periostin gene expres-
sion suggests that CCN2/CTGF stimulates the differentia-
tion of these cells that constitute elastic, membranous
tissues in between or close to calcified-tissues. Periostin is
thought to mediate tissue remodeling by modifying the
constitution of collagen fibers, while CCN2/CTGF
induces collagen synthesis (Fig. 6) and binds to gelatin in
Effects of rCCN2/CTGF on mRNA expression of osteoblast and PDL-related markers in MPL cells Figure 4
Effects of rCCN2/CTGF on mRNA expression of osteoblast and PDL-related markers in MPL cells. Confluent 
cultures of MPL cells were treated with rCCN2/CTGF (100 ng/ml, closed bars) or vehicle (dotted bars) for 24 hrs. Total RNA 
was purified, and 1 µg of each sample was reverse-transcribed and used for PCR. Alkaline phosphatase (ALPase), type I colla-
gen, and periostin mRNAs were shown to be up-regulated clearly by the addition of rCCN2/CTGF under exponential condi-
tions (25, 30, and 25 cycles, respectively) for amplification. The expression of GAPDH, used for an internal control, was almost 
the same among these samples.Cell Communication and Signaling 2005, 3:11 http://www.biosignaling.com/content/3/1/11
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vitro [21]. As such, periostin itself may collaborate with
CCN2/CTGF molecule in the remodeling of periodontal
ligament.
As well as at the mRNA expression level, rCCN2/CTGF
also stimulated collagen synthesis (Fig. 6). The turnover
of collagen in the periodontal ligament is believed to be
controlled by the balance between collagen synthesis and
degradation. In this respect, up-regulation of collagen
synthesis by rCCN2/CTGF may be accompanied by the
dynamic control of gene expression of matrix metallopro-
teinases (MMPs) or tissue inhibitors of matrix metallopro-
tainases (TIMPs) for the remodeling of periodontal
ligament [42]. It should be noted that induction of partic-
ular MMPs by CCN2/CTGF was reported to occur in vas-
cular endothelial cells. Therefore, CCN2/CTGF may play a
central role in promoting the remodeling of periodontal
ligament through direct and indirect actions.
According to a previous report [25], CCN2/CTGF expres-
sion was observed in dental laminas, invaginating epithe-
lium, and condensing mesenchyme at the bud stage.
Afterwards, strong expression was observed in the enamel
knot and preameloblasts; and CCN2/CTGF molecules
were also detected in stratum intermedium and underly-
ing dental mesenchyme, as well as in the dental epithe-
lium. Additionally, during experimental tooth
movement, CCN2/CTGF was highly expressed in osteob-
lasts around the periodontal ligament [42]. In this study,
we confirmed the ccn2/ctgf expression and cell biological
effects of CCN2/CTGF in vitro, by using MPL cell cultures.
Overall, our results support the in vivo findings mentioned
Effects of rCCN2/CTGF on ALPase activity from MPL cells Figure 5
Effects of rCCN2/CTGF on ALPase activity from 
MPL cells. When MPL cells reached confluence, the culture 
medium was replaced with α-MEM containing 1% FBS, and 
the cells were then cultured with various concentrations of 
rCCN2/CTGF. After 48 hrs, the cell layers were collected, 
and ALPase activity was determined as described in "Materi-
als and Methods." Values represent the averages ± SD of 3 
separate experiments. Asterisks denote statistically signifi-
cant differences from the vehicle-treated control at the sig-
nificance level of *p < 0.01.
Effect of rCCN2/CTGF on the synthesis of collagen and total  protein in MPL cells Figure 6
Effect of rCCN2/CTGF on the synthesis of collagen 
and total protein in MPL cells. Various concentrations of 
rCCN2/CTGF were added to confluent cultures of MPL 
cells, and the cells were cultured for 12 hrs. Then, the cells 
were labeled with [3H] proline for another 12 hrs, after 
which their cell layers were collected for analysis. The radio-
activities of [3H] proline incorporated into total nascent pro-
teins and collagenase-digestable portions were measured as 
described in "Materials and Methods." Slashed and closed 
boxes indicate the collagen and total protein synthesis, 
respectively. Values represent the mean average ± SD (n = 
2). Asterisks denote statistically significant differences (**p < 
0.01, *p < 0.05) from the vehicle-treated control, except the 
double asterisks specifying a significant difference between 
the stimulation levels of total protein and collagen synthesis 
(as indicated by the bracket). Data were computed with the 
results of 2 independent series of experiments with multiple 
sample numbers.Cell Communication and Signaling 2005, 3:11 http://www.biosignaling.com/content/3/1/11
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above, together suggesting critical roles of CCN2/CTGF in
the development and remodeling of dental tissues.
Conclusion
In this study, expression of CCN2/CTGF in MPL cells was
confirmed in vitro. Utilizing this system, we uncovered the
potential of CCN2/CTGF to promote the growth and dif-
ferentiation of MPL cells. These findings indicate the crit-
ical roles of CCN2/CTGF in periodontal tissue
development and strongly suggest the utility of CCN2/
CTGF in periodontal tissue regeneration, as already
proven in articular cartilage.
Methods
Cells and Cell culture
The mouse periodontal ligament cell line (MPL) was
established from periodontal ligament explants from
extracted mandibular molars of a BALB/c mouse [27] and
maintained as described [28]. The cells were grown in
alpha-modified Eagle's medium (α-MEM; Nissui, Tokyo,
Japan) supplemented with 10% heat-inactivated fetal
bovine serum (FBS; JRH Biosciences, Lenexa, KS, USA),
and kanamycin (100 µg/ml) at 37°C in a humidified
atmosphere of 5% CO2 in air.
Production of recombinant connective tissue growth factor 
(rCCN2/CTGF)
Human  ccn2/ctgf  cDNA containing the entire coding
region was inserted into the plasmid expression vector
pcDNA3.1(-) (Invitrogen, Carlsbad, CA, USA), and the
vector was used to transform HeLa cells. The conditioned
medium of the HeLa cells was concentrated and purified
by heparin-affinity column and anti-CTGF/Hcs24 affinity-
column chromatography. Purity was determined by
immunoblotting and silver staining of SDS-PAGE gels,
and highly purified fractions were used for experiments.
The biological activity of rCCN2/CTGF was almost the
same as that of the factor purified from a human chond-
rosarcoma cell line (HCS-2/8), as determined by their bio-
logical activity toward chondrocytes.
Estimation of DNA synthesis
The mitogenic effect of rCCN2/CTGF was assessed by
measuring [3H] thymidine (Amersham Bioscience Corp.,
Piscataway, NJ; Specific activity 74 TBq/nmol) incorpora-
tion into MPL cells [29,30]. The cells were labeled with
[3H] thymidine (4.8 MBq/ml in DMEM) for 4 hrs, then
washed with phosphate-buffered saline (PBS), and col-
lected in 100 µl of PBS containing 0.25% trypsin (w/v)
and 0.02% EDTA (w/v). They were next harvested onto
glass-fiber paper filters (WALLAC, Turku, Finland) with a
semi-automatic microharvester (TOMTEC, Yamaguchi,
Japan), washed with PBS, and treated subsequently with
5% trichloroacetic acid (TCA). The radioactivity was deter-
mined with a Micro Beta PLUS (WALLAC).
Estimation of cell proliferation
The effect of rCCN2/CTGF on cell proliferation was
assessed by using Tetracolor-One (Seikagaku Corp.,
Tokyo, Japan) as instructed by the manufacturer.
Northern blotting
Ten micrograms of total RNA was electrophoresed in a
formaldehyde agarose gel and subsequently blotted onto
a nylon membrane. For hybridization probes, CCN2/
CTGF and CCN1/Cyr61 cDNA fragments were prepared
by RT-PCR with pairs of specific primers. Primers specific
for CCN2/CTGF [27] and CCN1/Cyr61 [28] were
described previously. These PCR products were radiola-
beled and used for hybridization as described earlier [20].
Reverse transcription-polymerase chain reaction (RT-
PCR)
By using ISOGEN (Nippon Gene, Tokyo, Japan)[31], we
extracted total cellular RNA from MPL cell cultures treated
with rCCN2/CTGF (100 ng/ml) or vehicle; and before RT-
PCR, the RNA was treated with RNase-free DNase I. Total
RNA (1 µg) was reverse-transcribed by using an RNA PCR
kit (Perkin Elmer, Branchburg, NJ), and the cDNA was
used as a template to amplify fibroblast or osteoblast-
related marker genes and murine CCN2/CTGF and
GAPDH genes by PCR using Taq GOLD polymerase (Per-
kin-Elmer). Primer sequences employed and PCR condi-
tions were as follow:
murine glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), sense 5'-CACCATGGAGAAGGCCGGGG-3'
and antisense 5'-GACGGACACATTGGGGGTAG-3'(418
bp); type I collagen, sense 5'-TCTCCACTCTTCTAG-
GTCCT-3' and antisense 5'-TTGGGTCATTTCCACATGC-
3'(250 bp); osteopontin, sense 5'-ACACTTTCACTC-
CAATCGTCC-3' and antisense 5'-TGCCCTTTCCGTTGTT-
GTCC-3'(239 bp); osteocalcin, sense 5'-
TCTGACAAACCTTCATGTCC-3' and antisense 5'-AAAT-
AGTGATACCGTAGATGCG-3'(198 bp); periostin, sense
5'-TGGTTCCTCTCCTGCCCTTA-3' and antisense 5'-
ACCATGCCGTGTTTCAGGTC-3'(556 bp); ALPase, sense
5'-GCCCTCTCCAAGACATATA-3' and antisense 5'-CCAT-
GATCACGTCGATATCC-3'(372 bp); Osf-2/Cbfa-1, sense
5'-GAGGGCACAAGTTCTATCTGGA-3' and antisense 5'-
GGTGGTCCGCGATGATGTC-3' (385 bp); murine CCN2/
CTGF, sense 5'-GGTAAGGTCCGATTCCTACCAGG-3' and
antisense 5'-CTAGAAAGGTGCAAACATGTAAC-3'(120
bp).
After pre-denaturation for 7 min at 94°C, the chain reac-
tion was repeated for 25 cycles to maintain exponential
conditions for amplifications (30 cycles for murine oste-
opontin). Each cycle consisted of denaturation at 94°C
for 1 min, with annealing and polymerization at 60°C for
2 min. Ten-micro liter samples were analyzed on 2%Cell Communication and Signaling 2005, 3:11 http://www.biosignaling.com/content/3/1/11
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agarose gels and stained with ethidium bromide along
with a 100 bp-ladder molecular size marker.
Alkaline phosphatase (ALPase) activity
The effect of rCCN2/CTGF on ALPase activity was assayed
according to the procedure of Majeska et.al. [32]. The cells
were homogenized in 0.5 ml of 0.9% NaCl and 0.2% Tri-
ton X-100 with a Polytron at 4°C, and centrifuged for 15
min at 12,000 × g. ALPase activity in the supernatant was
measured by using p-nitro phenyl phosphate (p-NP) as a
substrate. The supernatant was mixed with 0.5 M Tris-
HCL buffer (pH9.0) containing 0.5 mM p-NP and 0.5 mM
MgCl2. The sample was then incubated at 37°C for 30
min, and the reaction was stopped by the addition of a
0.25 volume of 1N NaOH. Hydrolysis of p-NP was
monitored as the change in absorbance at 415 nm with a
spectrometer (Amersham Bioscience Corp.). The protein
concentration was determined by using the BCA protein
assay system (Pierce, Rockford, IL). The activity was
defined in units, 1 unit being the enzyme activity hydro-
lyzing 1 nmol of p-NP per 1 mg protein in 30 min.
Collagen synthesis
The effect of rCCN2/CTGF on collagen synthesis was
assayed by measuring the incorporation of [3H] proline
(Amersham, 1.7 TBq/nmol) in collagenase-digestable
proteins [33-35]. When MPL cells reached confluence,
they were labeled with [3H] proline (37 MBq/ml) for 12
hrs and then collected into 1 ml of 50 mM Tris (pH7.2)
containing 0.2% Triton X-100 and 1 mM phenylmethyl-
sulfonyl fluoride (PMSF). Half of the solubilized
homogenate was digested with purified bacterial colla-
genase for 4 hrs at 37°C, and the other half was incubated
with the vehicle (control). The radioactivity in the sus-
pended protein was measured with a liquid scintillation
counter.
In situ hybridization
For generation of the antisense probe, a 120-bp fragment
of murine ccn2/ctgf cDNA corresponding to a non-coding
region was subcloned into the pGEM-T plasmid
(Promega, Madison, WI, USA), and riboprobes were syn-
thesized by using a DIG RNA labelling kit (Roche, Man-
nheim, Germany) or 35S-UTP(30TBq/nmol, Amersham
Biosciences Corp.) following the manufacturer's instruc-
tions. Sense probes were used as negative controls. After in
vitro  transcription, the labeling reaction mixture was
treated with DNase I, and the probes were precipitated
with ethanol, and then dissolved in 0.1% diethyl pyrocar-
bonate (DEPC)-treated double distilled water containing
0.01% dithiothreitol.
MPL cells cultured on glass slides were washed with PBS
and fixed with 4% paraformaldehyde (PFA)- 0.1%
sodium-cacodylate at 4°C for 2 hrs. The samples were
washed with PBS, and digestion with 1 µg/ml proteinase
K was then performed at room temperature for 10 min.
After having been washed with PBS, the samples were
treated with 2 mg/ml of glycine-PBS at room temperature
for 10 min, and immersed in 0.1 M triethanolamine-HCl
(pH 8.0). Thereafter acetic acid-anhydride (0.25% con-
centration) was added dropwise over a 5-min period, and
incubation was then continued for another 15 min. The
slides were rinsed with 4 × standard saline-citrate (SSC)
for 10 min twice, and immersed in pre-hybridization
buffer (3 × SSC and 50% formamide) at 70°C for 30 min
for blocking.
Hybridization was performed with a hybridization mix-
ture (50% formamide, 3 × SSC, 10% dextran sulfate, 1 µg/
ml of tRNA, 1 µg/ml of sonicated salmon sperm DNA,
and 1 µg/ml BSA) containing 0.4 µg/ml riboprobes at
55°C for 16 hrs in a humidified box. The slides were
washed 3 times for 20 min each time with 2 × SSC and
50% formamide at 55°C, while being shaken at 90
strokes/min to remove the excess riboprobe; and then
they were incubated at 37°C for 30 min with 20 µg/ml of
RNase A in NTE buffer [0.5 mM NaCl, 10 mM Tris-HCl
(pH 8.0) and 1 mM EDTA]. After having been rinsed in
NTE buffer at 37°C for 5 min, the slides were washed 3
times for 20 min each time with 0.5 × SSC at 37°C and
incubated at room temperature for 30 min in TBS buffer
[100 mM Tris-HCl (pH 9.5), 100 mM NaCl and 150 mM
NaCl] containing 1% normal goat serum. Next, the
sections were incubated with 1/500-diluted alkaline phos-
phatase (AP)-conjugated sheep anti-digoxigenin antibody
at room temperature for 1 hr. To visualize digoxigenin-
labeled riboprobe-tissue mRNA complexes, we incubated
the sections in a freshly prepared solution of nitro blue
tetrazolium chloride (NBT) and 5-bromo-4-chloro-3-
indolylphosphate (BCIP) in an alkaline buffer [100 mM
Tris-HCl (pH9.5), 100 mM NaCl and 50 mM MgCl2] con-
taining 1 mM levamisole in a dark room at room temper-
ature. Finally, the slides were washed in distilled water 3
times and mounted in aqueous mounting material.
Table 1: Expression profiles of the phenotypic markers in MPL 
versus osteoblastic cells
Cells Basal osf-2/cbfa1 Induction by CCN2/CTGF
ALP opn ocn periostin
MPL - + - - +
MC3T3-E1* + + + + N.D.
*Nishida et al. [24]Cell Communication and Signaling 2005, 3:11 http://www.biosignaling.com/content/3/1/11
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Statistical methods
The statistical difference between treated or control sam-
ples was assessed with Student's t-test. All experiments
were repeated at least twice, and similar results were
obtained.
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